Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites.
Saved in:
| Title: | Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites. |
|---|---|
| Authors: | Hammitt LL; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Buchwald UK; Merck & Co., Inc., Rahway, NJ 07065, USA., McCauley J; Merck & Co., Inc., Rahway, NJ 07065, USA., Shekar T; Merck & Co., Inc., Rahway, NJ 07065, USA., Fu W; Merck & Co., Inc., Rahway, NJ 07065, USA., Cheon K; Merck & Co., Inc., Rahway, NJ 07065, USA., Sterling T; Merck & Co., Inc., Rahway, NJ 07065, USA., Tamms G; Merck & Co., Inc., Rahway, NJ 07065, USA., Banniettis N; Merck & Co., Inc., Rahway, NJ 07065, USA., Musey L; Merck & Co., Inc., Rahway, NJ 07065, USA., LeBlanc JJ; Division of Microbiology, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, NS B3H 1V8, Canada.; Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS B3K 6R8, Canada., Weatherholtz R; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Riley DP; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Denny E; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Tso C; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Roessler K; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA., Santosham M; Department of International Health, Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. |
| Source: | Vaccines [Vaccines (Basel)] 2025 Dec 19; Vol. 14 (1). Date of Electronic Publication: 2025 Dec 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines14010003 |
